|
|
 |
|
Viewing report
|
|
|
|
Infectious Diseases Vaccine Market Overview
Datamonitor, Oct 2010, Pages: 196
Introduction
Long being regarded as an unattractive market, vaccines have re-emerged as successful growth driver for Big Pharma. The launch and rapid uptake of novel, high-price products such as Wyeth’s Prevnar or Merck & Co’s Gardasil, along with the emergence of novel vaccine technologies and favourable legislation have brought vaccines back into the main focus of pharmaceutical and biotech companies.
Features and benefits
- Market overview with current market assessment in terms of leading players, brands and geographies
- In-depth analyses of the leading 5 players’ portfolios, R&D pipelines, sales trends, geographic spread, licensing patterns and strategic outlook
- Discussion of key developments shaping the sector: new technologies, indications and geographies
- Snapshot profiles of second tier companies in the sector
Highlights
- Driven by its increasing commercial potential, the vaccines sector has been subject to significant consolidation over the last 5 years. While some of this recent activity has paved the way for newer market entrants, at the same time, established players have sought to diversify their portfolios through new acquisitions.
- Key opportunities for vaccine manufacturers lie in the exploitation of novel targets with a high unmet need. Development of candidates for these indications can be facilitated by novel technologies, such as adjuvants, alternative production and delivery techniques, and novel approaches in antigen design.
- Faced with limited growth prospects in the western markets, companies are increasingly turning towards emerging countries. The higher disease burden, greater medical unmet needs combined with rapid economic growth, a growing affluent middle class and private sector in these countries represents significant potential for market expansion.
Your key questions answered
- Get a comprehensive, insightful commercial overview of the vaccines market
- Learn about the strategies of the Big 5 players, their strengths, weaknesses, similarities and differences
- Gain insight into the future directions and growing strategic importance of vaccines for Big Pharma
|
|
|
|
